Source: International Congress 2017 – Novel and old entities
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Thillai (Cambridge, United Kingdom). Development of a multivariate model to predict clinical deterioration in pulmonary sarcoidosis. 3844

Member's Comments

No comment yet.

Related content which might interest you: A structured clinical model for predicting the probability of pulmonary embolism Source: Eur Respir J 2004; 24: Suppl. 48, 559s Year: 2004 A comparison of published multidimensional indices to predict outcome in idiopathic pulmonary fibrosis Source: ERJ Open Res, 3 (1) 00096-2016; 10.1183/23120541.00096-2016 Year: 2017 A stepwise composite echocardiographic score predicts severe pulmonary hypertension in patients with interstitial lung disease Source: ERJ Open Res, 4 (2) 00124-2017; 10.1183/23120541.00124-2017 Year: 2018 Diagnostic and prognostic value of a diagnostic CT regression model in suspected pulmonary hypertension Source: International Congress 2019 – Pulmonary arterial hypertension: recent advances from the bedside Year: 2019 Simple logistic models in the development of a quality of life questionnaire specific for patients with chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 309s Year: 2005 A simple assessment of dyspnea as a prognostic indicator in idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis Year: 2010 Development of a predictive model for chronic obstructive pulmonary disease onset with identification and ranking of risk factors Source: Virtual Congress 2021 – COPD burden, epidemiology and management Year: 2021 Clinical manifestations and prediction rules in patients with pulmonary embolism and prior respiratory disease Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism Year: 2011 Prognostic usefulness of severity scales for the initial assessment of elderly people with a diagnosis of pneumonia due to COVID-19. Design of a multivariate predictive model of mortality. Source: Virtual Congress 2021 – COVID - 19 risk predictions Year: 2021 Clinical features and predictive factors for acute exacerbation of idiopathic pulmonary fibrosis Source: Annual Congress 2007 - Clinical aspects of idiopathic pulmonary fibrosis Year: 2007 Validation of two predictive models for survival in pulmonary arterial hypertension Source: Eur Respir J 2015; 46: 152-164 Year: 2015 Biomarkers model for prediction of hospitalisation duration and pulmonary embolism outcome Source: Virtual Congress 2021 – Pulmonary embolism in non-COVID-19 and COVID-19 patients Year: 2021 Risk factors of poor outcomes after admission for a COPD exacerbations. Multivariate logistic predictive models Source: International Congress 2015 – COPD: interesting notes Year: 2015 Comparison of two clinical prediction rules and implicit assessment for suspected pulmonary embolism Source: Eur Respir J 2002; 20: Suppl. 38, 238s Year: 2002 Advances in the clinical prediction rules that are used to assess patients with possible pulmonary embolism Source: International Congress 2018 – Advances in idiopathic pulmonary fibrosis treatment, tracheobronchial reconstruction using bioengineering and clinical prediction rules for diagnosing pulmonary embolism Year: 2018 Comparison of three clinical prediction rules among patients with suspected pulmonary embolism Source: Eur Respir J 2004; 24: Suppl. 48, 685s Year: 2004 Predictive systemic biomarkers of pulmonary fibrosis after COVID-19 pneumonia Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases Year: 2021 Adequate use of pulmonary embolism clinical prediction rule in COPD patients Source: Eur Respir J 2011; 37: 219-220 Year: 2011 Idiopathic pulmonary fibrosis: independent physiologic variables in the prediction of survival Source: Annual Congress 2007 - Clinical aspects of idiopathic pulmonary fibrosis Year: 2007 Clinical course of idiopathic pulmonary fibrosis (IPF): Prediction and outcome Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011